systemic lupus erythematosus: An autoimmune multi-organ disease typically associated with vasculopathy and autoantibody production. Most patients have antinuclear antibodies (ANA). The presence of anti-dsDNA or anti-Smith antibodies are highly-specific.
| Name | SLE_NOS |
|---|---|
| Long name | Systemic lupus erythematosus, unspecified |
| Hospital Discharge registry | ICD-10: M329 |
| Cause of Death registry | ICD-10: M329 |
| First defined in version | DF2 |
| Latin name | Lupus erythematosus disseminatus non specificatus |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 442 | 374 | 68 |
| Unadjusted prevalence (%) | 0.20 | 0.30 | 0.07 |
| Mean age at first event (years) | 47.46 | 46.71 | 51.57 |
| Case fatality at 5-years (%) | 3.17 | 3.48 | 1.47 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 6.0 | 7.0 | 4.0 |
| Recurrence at 6 months (%) | 69.23 | 69.25 | 69.12 |
before Systemic lupus erythematosus, unspecified
after Systemic lupus erythematosus, unspecified
Loading survival analyses plot…
Loading survival analyses table…